Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw
Latest AUM
₹ 167.2 Cr.
NAV as on 29 may, 2026
₹ 21.72
Fund Details
Portfolio Composition Analysis
Sector Allocations
Portfolio Updated on: 29 may, 2026
Top 10 Holdings
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.50% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.50% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.25% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.73% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.98% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.16% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.16% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.90% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.89% |
Debt & Credit Risk Analysis
| Alpha | 1.38% |
| Beta | 0.68% |
| Sharpe Ratio | 1.07% |
| Standard Deviation | 12.57% |
Returns Analysis
| Tenure | Absolute | Annualised | Category Average |
|---|---|---|---|
| 3 Months | 1.36% | NA | 6.12% |
| 6 Months | 2.51% | NA | 12.92% |
| 9 Months | 10.91% | NA | 4.47% |
| 1 Year | 15.24% | 15.24% | 6.04% |
| 2 Years | 26.65% | 12.54% | 24.93% |
| 3 Years | 75.45% | 20.61% | 25.71% |
| 5 Years | 81.89% | 12.71% | 19.91% |
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw is one Equity mutual fund offered by Edelweiss Mutual Fund. Launched on 26 Oct 2020, the fund aims Long Term Capital appreciation. Passive investment in equity and equity related securities replicating the composition of MSCI India Domestic & World Healthcare 45 Index, subject to tracking error. It manages assets worth ₹167.2 crore as on Tue Mar 31, 2026. The expense ratio stands at 1.06%.
Bhavesh Jain has experience Prior to joining Edelweiss Mutual Fund he was previously associated with Edelweiss Securities Limited as SGX Nifty Arbitrage Trader.
Amit Vora has experience Antique Stock Broking Ltd, D.E. Shaw India Securities Pvt. Ltd, Derivium Tradition Securities (India) Pvt Ltd, Tower Capital & Securities Pvt Ltd and B&K Securities
Top Performing Mutual Funds
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More Funds from Edelweiss Mutual Fund
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct-growth | 167.2 | +4.56% | +1.50% | +2.79% | +15.86% | +21.27% | +13.35% |
| Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-growth | 167.2 | +4.51% | +1.36% | +2.51% | +15.24% | +20.61% | +12.71% |
| Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Direct-idcw | 167.2 | +4.56% | +1.50% | +2.79% | +15.86% | +21.27% | +13.35% |
growth is based on 1-month returns of the funds
Top Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Nippon India Pharma Fund Direct-growth | 7,898.2 | +2.37% | +2.91% | +2.90% | +5.82% | +22.93% | +13.62% |
| Nippon India Pharma Fund-growth | 7,898.2 | +2.29% | +2.68% | +2.45% | +4.88% | +21.84% | +12.60% |
| Nippon India Pharma Fund-idcw | 7,898.2 | +2.29% | +2.68% | +2.45% | +4.88% | +21.84% | +12.60% |
| Nippon India Pharma Fund Direct-idcw | 7,898.2 | +2.37% | +2.91% | +2.90% | +5.82% | +22.93% | +13.62% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,293.1 | +2.58% | +6.59% | +2.18% | +7.19% | +27.68% | +16.50% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth | 6,293.1 | +2.53% | +6.38% | +1.79% | +6.32% | +26.62% | +15.49% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,293.1 | +2.58% | +6.59% | +2.18% | +7.19% | +27.68% | +16.50% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw | 6,293.1 | +2.53% | +6.38% | +1.79% | +6.32% | +26.62% | +15.49% |
| SBI Healthcare Opportunities Fund-growth | 4,063.6 | +4.56% | +6.46% | +5.11% | +9.86% | +24.70% | +15.48% |
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,063.6 | +4.65% | +6.73% | +5.64% | +10.98% | +26.01% | +16.71% |
Top funds are based on Fund AUM
Top Equity Funds
| Fund name | ||||
|---|---|---|---|---|
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹530.58 | +26.01% | +16.71% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹368.63 | +26.01% | +16.71% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | ₹44.93 | +27.68% | +16.50% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | ₹27.14 | +27.68% | +16.50% | — |
| Dsp Healthcare Fund Direct-growth | ₹45.57 | +24.25% | +15.96% | — |
| Dsp Healthcare Fund Direct-idcw | ₹26.35 | +24.25% | +15.96% | — |
| Mirae Asset Healthcare Fund Direct-growth | ₹47.19 | +26.14% | +15.83% | — |
| Mirae Asset Healthcare Fund Direct-idcw | ₹28.42 | +26.14% | +15.83% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth | ₹41.41 | +26.62% | +15.49% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw | ₹24.16 | +26.62% | +15.49% | — |
growth is based on 5Y returns of the funds
Historical NAV
| Date | NAV |
|---|---|
| 29 May 2026 | ₹21.72 |
| 27 May 2026 | ₹21.98 |
| 26 May 2026 | ₹21.91 |
| 22 May 2026 | ₹22.02 |
| 21 May 2026 | ₹22.20 |
| 20 May 2026 | ₹22.12 |
| 19 May 2026 | ₹22.06 |
| 18 May 2026 | ₹21.90 |
| 15 May 2026 | ₹21.82 |
| 14 May 2026 | ₹21.84 |
| 13 May 2026 | ₹21.45 |
| 12 May 2026 | ₹21.36 |
| 11 May 2026 | ₹21.44 |
| 08 May 2026 | ₹21.34 |
| 07 May 2026 | ₹21.41 |
| 06 May 2026 | ₹21.45 |
| 05 May 2026 | ₹21.18 |
| 04 May 2026 | ₹21.09 |
| 30 Apr 2026 | ₹20.96 |
| 29 Apr 2026 | ₹20.78 |
| 28 Apr 2026 | ₹20.79 |
| 27 Apr 2026 | ₹20.79 |
| 24 Apr 2026 | ₹20.51 |
| 23 Apr 2026 | ₹20.78 |
| 22 Apr 2026 | ₹20.50 |
| 21 Apr 2026 | ₹20.48 |
| 20 Apr 2026 | ₹20.54 |
| 17 Apr 2026 | ₹20.61 |
| 16 Apr 2026 | ₹20.50 |
| 15 Apr 2026 | ₹20.58 |
Portfolio Updated on: 30 May, 2026
Fund Growth & Size Analysis
Compare Mutual funds
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw Returns Comparison
Compare Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw with any MF,
EYF, stock or index
No funds found for your search.
Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw FAQ'S
- Sharpe Ratio: 1.07%
- Standard Deviation: 12.57%
- Beta: 0.68%
- Alpha: 1.38%
Additional important ratios:
As of Tue Mar 31, 2026, the total assets managed under Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw stand at approximately ₹ 167.2 crore.
The Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw has delivered the following short-term performance:
- 3 Months Return: 1.36%
- 6 Months Return: 2.51%
The historical growth of the Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw is reflected through its CAGR returns:
- 3 Year CAGR: 20.61%
- 5 Year CAGR: 12.71%
- Return Since Launch: 14.88%
The portfolio of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw is distributed across different asset classes as follows:
- Equity: 99.70%
- Debt Instruments: 0.27%
- Other Assets: 0.02%
The Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw is managed by Amit Vora, representing Edelweiss Mutual Fund.
The Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw investments are allocated across market caps in the following manner:
- Large Cap Stocks: 1.00%
- Mid Cap Stocks: 1.00%
- Small Cap Stocks: 1.00%
Top stock holdings of Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw include:
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.50% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.50% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.25% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.73% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 10.98% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.16% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.16% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 10.90% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 10.89% of the portfolio
Major sector exposures in Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Regular-idcw are:
- Healthcare – accounts for 1,041.37% of the portfolio
